Bipolar RF Sales Injunction Vacated In Appeals Decision On ArthroCare Case
This article was originally published in The Gray Sheet
Executive Summary
Smith & Nephew is evaluating whether to re-enter the bipolar radiofrequency (RF) market now that a sales injunction has been lifted by a Washington, D.C. federal appeals court
You may also be interested in...
ArthroCare completes Opus acquisition
Coblation technology developer finalizes $130 mil. purchase of soft tissue orthopedic repair system maker Opus Medical Nov. 15 (1"The Gray Sheet" Sept. 13, 2004, p. 14). ArthroCare expects Opus to generate $16 mil.-$17 mil. in 2004 revenue from AutoCuff anchoring system sales...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.